Monitor for upcoming clinical catalysts, cash runway updates, or potential secondary offering. RA Capital's substantial selling in a small-cap biotech could signal waning institutional support. Watch for any 8-K filings regarding financing or pipeline setbacks.
Price Chart
Executive Summary
Two insiders at Werewolf Therapeutics (HOWL) sold shares in a cluster, including Director Luke Evnin and 10% owner RA Capital Management, totaling ~$92K in open-market sales. RA Capital Management alone sold an additional ~$271K in the surrounding window, bringing total insider selling to ~$363K (~1.9% of the $19M market cap), which is significant relative to the company's size. The selling by a large institutional holder raises concerns about confidence in the company's near-term prospects, especially with no insiders buying.
Key Financial Metrics
Key Facts
- Director Luke Evnin sold 76.9K shares at $0.37 for ~$28K on 2026-06-09.
- 10% owner RA Capital Management sold 159.1K shares at $0.40 for ~$64K on 2026-06-12.
- Total cluster sales of $92K represent ~0.48% of market cap.
- Including cross-filing RA Capital sales, total insider selling in the period is ~$363K (~1.9% of market cap).
- No C-suite executives or insiders purchased shares during the cluster window.
Financial Impact
Total insider selling of $363K (~1.9% of market cap) in a narrow window
Risk Factors
- Further insider selling or institutional exodus
- Potential dilutive financing if cash runway is short
- Negative clinical data or regulatory delay
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-HOWL-1781647307013 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | S-4/A | $0.9806 | awaiting T+5 | — | $0.9790 (+0.16%) |
Sep 22, 2026 4w ago | S-4 | $0.9894 $0.9223 | ▲ +6.78% | ▲ +6.11% | $0.9790 (+1.05%) |
Sep 21, 2026 5w ago | SC 13G | $0.9800 $0.9300 | ▼ −5.10% | ▼ −4.08% | $0.9790 (−0.10%) |
Aug 21, 2026 9w ago | 425 | $0.8740 $0.9433 | ▲ +7.93% | ▲ +7.46% | $0.9790 (+12.01%) |
Aug 21, 2026 9w ago | 8-K | $0.8740 $0.9433 | ▲ +7.93% | ▲ +7.46% | $0.9790 (+12.01%) |
Aug 21, 2026 9w ago | Press Release | $0.8740 $0.9433 | ▼ −7.93% | ▼ −7.46% | $0.9790 (−12.01%) |
Jul 31, 2026 12w ago | 8-K | $0.3531 $0.3971 | ▲ +12.46% | ▲ +8.95% | $0.9790 (+177.26%) |
Jul 31, 2026 12w ago | Press Release | $0.3531 $0.3971 | ▲ +12.46% | ▲ +8.95% | $0.9790 (+177.26%) |
Jun 29, 2026 17w ago | 144 | $0.3599 $0.3200 | ▲ +11.09% | ▲ +11.69% | $0.9790 (−172.02%) |
Jun 29, 2026 17w ago | 144 | $0.3599 $0.3200 | ▲ +11.09% | ▲ +11.69% | $0.9790 (−172.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers